A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how ...
Chrome's WebMCP guidance warns that AI agents can be manipulated through the tools they are built to trust.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results